Trials / Completed
CompletedNCT00652717
Study To Assess The Efficacy Of A Cholesterol Lowering Drug On Top Of Statins In Patients After Myocardial Infarction (MI)(0653A-150)
A Multicenter, Open Study To Evaluate The Efficacy Of Ezetimibe 10 Mg Added On Statin Therapy, In Reducing LDL Cholesterol To Target Levels In Patients After Acute Coronary Syndrome
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 280 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Collecting local data, safety and experience trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ezetimibe | Ezetimibe 10 mg daily for 42 days. |
| DRUG | simvastatin | simvastatin (prescribed clinically suitable dose by the physician), for mean follow up of 42 days. |
Timeline
- Start date
- 2005-02-01
- Primary completion
- 2005-02-15
- Completion
- 2005-08-04
- First posted
- 2008-04-04
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00652717. Inclusion in this directory is not an endorsement.